Cerity Partners LLC Acquires 104,401 Shares of CVS Health Corporation $CVS

Cerity Partners LLC grew its position in CVS Health Corporation (NYSE:CVS) by 24.2% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 536,496 shares of the pharmacy operator’s stock after purchasing an additional 104,401 shares during the period. Cerity Partners LLC’s holdings in CVS Health were worth $40,446,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Ashton Thomas Private Wealth LLC raised its stake in shares of CVS Health by 20.8% during the first quarter. Ashton Thomas Private Wealth LLC now owns 9,381 shares of the pharmacy operator’s stock worth $636,000 after buying an additional 1,615 shares during the last quarter. Arete Wealth Advisors LLC boosted its stake in CVS Health by 31.2% in the first quarter. Arete Wealth Advisors LLC now owns 7,740 shares of the pharmacy operator’s stock valued at $524,000 after acquiring an additional 1,839 shares during the last quarter. Ascent Group LLC acquired a new stake in CVS Health during the 1st quarter worth $497,000. Woodline Partners LP raised its position in shares of CVS Health by 95.1% during the 1st quarter. Woodline Partners LP now owns 106,518 shares of the pharmacy operator’s stock valued at $7,217,000 after acquiring an additional 51,925 shares during the last quarter. Finally, Bayforest Capital Ltd acquired a new position in shares of CVS Health in the 1st quarter valued at $331,000. Institutional investors own 80.66% of the company’s stock.

Analyst Ratings Changes

CVS has been the subject of a number of recent analyst reports. Leerink Partners upped their price objective on CVS Health from $86.00 to $95.00 and gave the company an “outperform” rating in a report on Thursday, October 16th. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of CVS Health in a research note on Wednesday, December 10th. Jefferies Financial Group boosted their price objective on shares of CVS Health from $92.00 to $98.00 in a report on Thursday, October 30th. Raymond James Financial upped their target price on shares of CVS Health from $75.00 to $90.00 in a research note on Friday, October 31st. Finally, Wolfe Research lifted their price target on shares of CVS Health from $85.00 to $100.00 and gave the stock an “outperform” rating in a research report on Monday, December 8th. Two analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, CVS Health presently has an average rating of “Moderate Buy” and a consensus price target of $94.86.

CVS Health Price Performance

Shares of NYSE CVS opened at $80.51 on Friday. The company has a fifty day moving average price of $78.65 and a 200 day moving average price of $73.74. The firm has a market cap of $102.20 billion, a PE ratio of 211.87, a PEG ratio of 0.73 and a beta of 0.48. The company has a current ratio of 0.83, a quick ratio of 0.63 and a debt-to-equity ratio of 0.83. CVS Health Corporation has a 1-year low of $46.34 and a 1-year high of $85.15.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. The company had revenue of $102.87 billion for the quarter, compared to analyst estimates of $98.85 billion. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The company’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same period in the previous year, the company posted $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Research analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd will be paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 3.3%. The ex-dividend date of this dividend is Thursday, January 22nd. CVS Health’s dividend payout ratio (DPR) is currently 700.00%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.